Related Experiment Video
Updated: Nov 15, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Mistaken administration of a repeat loading dose of Degarelix leading to acute psychosis
Musaab Hamdoon1, Maria Satchi1, Fay Fawke1
1Department of Urology, Darent Valley Hospital, Dartford DA2 8DA, UK.
Abstract:
Advanced and metastatic prostate cancer is often managed with hormonal blockage. Luteinising hormone-releasing hormone antagonists achieve rapid testosterone suppression and are used for the treatment of advanced or metastatic prostate cancer. Degarelix is a luteinising hormone-releasing hormone antagonist and is given as a loading dose, followed by a monthly maintenance dose. We report a case where a patient was inadvertently given a second loading dose of Degarelix that resulted in acute psychosis in the form of panic attacks, delusions, suicidal thoughts, insomnia and some visual hallucinations, which are not reported as side-effects of Degarelix.
Related Concept Videos
Desensitization and Tachyphylaxis
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

